Company Updates

DMX-200 is an adjunct therapy in which patients who are already on the standard of care angiotensin II type I receptor blocker (irbesartan) are also dosed with a chemokine receptor CCR2 blocker.

Following the official admission as a trading member of SGX-ST and clearing member of CDP on 9 June 2017.

As discussed, here are a few FY17 highlights. Works either as one paragraph or as bullet points sentence by sentence.

In today’s society, consumers needs are shaping the demand for “greener and more natural products”, which can be seen throughout almost every industry.

ThinCats Australia’s first peer to business lending (marketplace) platform has since inception in 2015 successfully completed 2 seed rounds of capital raising.

Jumbo is a leading digital retailer of official government and charitable lotteries.

Hartleys Limited has begun coverage on its Montepuez Ruby Project along with Balama Graphite project, located in the northern Mozambique.

ChimpChange Limited (ASX:CCA) is Australia’s first digital banking platform, is pleased to present the company’s quarterly report on the businesses updated progress.

OpenDNA Limited (ASX: OPN) has recently announced the a signed customer agreement with Endeavour Drinks Group, a business element operated by Woolworths Limited.